BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Report

KNOA PHARMA, FORMERLY REPORTED AS, PURDUE PHARMA L.P.

via BROWNSTEIN HYATT FARBER SCHRECK, LLP

2nd Quarter (Apr 1 - June 30) · 2025Posted Jul 17, 2025Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: KNOA PHARMA, FORMERLY REPORTED AS, PURDUE PHARMA L.P.
Description: law firm
Location: District of Columbia · United States of America

Registrant

Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Monitoring legislative and regulatory activities impacting the pharmaceutical industry
LobbyistsALFRED MOTTUR · NADEAM ELSHAMI · DEEMA TARAZI

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

KNOA PHARMA, FORMERLY REPORTED AS, PURDUE… — Receipts Report